Correlated with this, high levels of viral replication prior to therapeutic administration of the NAbs were detected, whereas M8 and M170 treatment at all indicated time-points resulted in largely reduced viral titers with a clear trend for greater reduction with earlier treatment (Fig. 1 F, down).
← all excerpts
Structural and molecular basis for foot-and-mouth disease virus neutralization by two potent protective antibodies.
1
—
—